Search results
This study found that the overall risk of breast cancer among hormonal contraceptive users is low. Because of the low baseline risks in the age groups using hormonal contraception (ie, premenopausal women), the risk difference between hormonal contraception users and nonusers is small.
16 paź 2024 · By Nina Agrawal. Published Oct. 16, 2024 Updated Oct. 17, 2024. A study published Wednesday found that women using contraceptive intrauterine devices that deliver a certain hormone are at...
6 dni temu · In the United States, about 1 in 10 women ages 15 to 49 uses an IUD or other form of long-acting reversible contraception, according to CDC data. A new study adds to a growing set of evidence that ...
4 lip 2024 · Mirena is a type of intrauterine devices (IUD) that prevents pregnancy for up to 6 years. It works by releasing a hormone called levonorgestrel, a type of progestin. Because of this, Mirena is...
23 wrz 2022 · Findings In this cohort study of 2900 premenopausal women with early breast cancer enrolled in the prospective Cancer Toxicity study, 54.2% of patients reported contraceptive use at the time of diagnosis, with most patients using hormonal methods. Contraceptive use significantly decreased after primary treatment and during follow-up, when most ...
2 paź 2024 · Key Objective. Is hormonal contraception use associated with the risk of breast cancer (BC) for women with germline mutations in BRCA1 and BRCA2? Knowledge Generated.
7 gru 2017 · Our results suggest the rapid disappearance of excess risk of breast cancer after discontinuation of use among women who have used hormonal contraceptives for short periods, whereas the risk...
